Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Dec 16, 2021
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help Veterans who have recently finished treatment for lung cancer. After treatment, many Veterans struggle with symptoms like shortness of breath, tiredness, and feelings of anxiety about their health. The study will test a program called multi-targeted telerehabilitation, which means patients will receive rehabilitation support through video calls and online resources. The goal is to help them feel better, both physically and mentally, and improve their overall quality of life.
To be eligible for this trial, participants need to be adult Veterans who have been diagnosed with stage I-III A/B lung cancer and have completed their main treatment within the last 1 to 6 months. However, those who have serious other health issues that would make it hard to take part in exercise or follow the program will not be included. If eligible, participants can expect to receive tailored support from the comfort of their own homes, helping them to manage symptoms and improve their health after cancer treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult Veterans with a history of stage I-III A/B lung cancer, and
- • Completed curative intent therapy (i.e., lung cancer resection surgery, definitive radiation, or concurrent chemoradiation) within 1-6 months
- Exclusion Criteria:
- * Adult Veterans with any comorbid conditions that preclude participation in exercise and telerehabilitation:
- • Orthopedic conditions (e.g., bilateral below-knee amputation), or
- • Severe cardiopulmonary disease (e.g., unstable arrhythmias including ventricular tachycardia, heart failure with systolic ejection fraction \< 25%, chronic hypoxemia needing \> 5 L/min oxygen supplementation at rest), or
- • Inability to follow directions or provide informed consent (e.g., moderate to severe dementia), or
- • Enrolled in hospice, or
- • With an estimated life expectancy of \< 6 months
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Aurora, Colorado, United States
Patients applied
Trial Officials
Duc M. Ha, MD MAS
Principal Investigator
Rocky Mountain Regional VA Medical Center, Aurora, CO
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials